Franklin Resources’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,632
Closed -$22.3K 2931
2023
Q4
$22.3K Hold
1,632
﹤0.01% 2570
2023
Q3
$25.3K Sell
1,632
-423
-21% -$8.07K ﹤0.01% 2580
2023
Q2
$44.4K Hold
2,055
﹤0.01% 2620
2023
Q1
$36.5K Hold
2,055
﹤0.01% 2215
2022
Q4
$34.8K Hold
2,055
﹤0.01% 2242
2022
Q3
$68K Buy
2,055
+31
+2% +$1.58K ﹤0.01% 2165
2022
Q2
$114K Sell
2,024
-968
-32% -$50.5K ﹤0.01% 2127
2022
Q1
$174K Buy
2,992
+34
+1% +$2.13K ﹤0.01% 2189
2021
Q4
$213K Buy
+2,958
New +$247K ﹤0.01% 2213

Other funds holding NXTC

Franklin Resources's NXTC Position: Q1 2024 in Review

Franklin Resources sold out of NextCure (NXTC) in Q1 2024, closing a stake of 1,632 shares — an estimated $22.3K sold.

Franklin Resources first reported a position in NXTC in Q4 2021 and held it in 9 quarters. The position peaked at $213K in Q4 2021. 47 funds tracked by Wall St. Rank hold NXTC as of Q1 2024.

  • Franklin Resources reported no remaining NextCure position as of Q1 2024 after selling out during the quarter.
  • Franklin Resources sold 1,632 NextCure shares in Q1 2024, an estimated $22.3K.
  • Franklin Resources first reported a position in NextCure in Q4 2021 and held it in 9 quarters.
  • Franklin Resources's NextCure position peaked at $213K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held NextCure as of Q1 2024.

Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.